Contemporary assessment and pharmacotherapy of Tourette syndrome (original) (raw)

• Jankovic J. Tourette’s syndrome.N Engl J Med 345: 1184–1192, 2001.
  Article PubMed CAS Google Scholar
• Leckman JF. Tourette’s syndrome.Lancet 360: 1577–1586, 2002.
  Article PubMed Google Scholar
• Piacentini J, Chang S. Behavioral treatments for Tourette syndrome and tic disorders: state of the art.Adv Neurol 85: 319–331, 2001.
  PubMed CAS Google Scholar
• Craighead WE, Craighead LW. The role of psychotherapy in treating psychiatric disorders.Med Clin North Am 85: 617–629, 2001.
  Article PubMed CAS Google Scholar
• Foa EB, Franklin ME, Moser J. Context in the clinic: how well do cognitive-behavioral therapies and medications work in combination?Biol Psychiatry 52: 987–997, 2002.
  Article PubMed Google Scholar
• Wells KC, Pelham WE, Kotkin RA, Hoza B, Abikoff HB, Abramowitz A et al. Psychosocial treatment strategies in the MTA study: rationale, methods, and critical issues in design and implementation.J Abnorm Child Psychol 28: 483–505, 2000.
  Article PubMed CAS Google Scholar
• Wilhelm S, Deckersbach T, Coffey BJ, Bohne A, Peterson AL, Baer L. Habit reversal versus supportive psychotherapy for Tourette’s disorder: a randomized controlled trial.Am J Psychiatry 160: 1175–1177, 2003.
  Article PubMed Google Scholar
• Temel Y, Visser-Vandewalle V. Surgery in Tourette syndrome.Mov Disord 19: 3–14, 2004.
  Article PubMed Google Scholar
• Houeto JL, Karachi C, Mallet L, Pillon B, Yelnik J, Mesnage V et al. Tourette’s syndrome and deep brain stimulation.J Neurol Neurosurg Psychiatry 76: 992–995, 2005.
  Article PubMed CAS Google Scholar
• Goetz CG, Kompoliti K. Rating scales and quantitative assessment of tics.Adv Neurol 85: 31–42, 2001.
  PubMed CAS Google Scholar
• Scahill L, King RA, Schultz RT, Leckman JF. Selection and use of diagnostic and clinician rating instruments. In: Tourette’s syndrome: tics, obsessions, compulsions: developmental psychopathology and clinical care (Leckman JF, Cohen DJ, eds), pp 310–324. New York: Wiley, 1999.
  Google Scholar
• Leckman JF, Riddle MA, Hardin MT, Ort SI, Swartz KL, Stevenson J, et al. The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity.J Am Acad Child Adolesc Psychiatry 28: 566–573, 1989.
  Article PubMed CAS Google Scholar
• Scahill L, Riddle M, McSwiggin-Hardin M, Ort SI, King RA, Goodman WK et al. Children’s Yale-Brown Obsessive Compulsive Scale: reliability and validity.J Am Acad Child Adolesc Psychiatry 36: 844–852, 1997.
  Article PubMed CAS Google Scholar
• Kwak C, Dat Vuong K, Jankovic J. Premonitory sensory phenomenon in Tourette’s syndrome.Mov Disord 18: 1530–1533. 2003.
  Article PubMed Google Scholar
• The Tourette Syndrome Classification Group. Definitions and classifications of tic disorders.Arch Neurol 50: 1013–1016, 1993.
  Article Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual, fourth edition: treatment revision. Washington, DC: American Psychiatric Association Press, 2000.
  Book Google Scholar
• Jankovic J. Differential diagnosis and etiology of tics.Adv Neurol 85: 15–29, 2001.
  PubMed CAS Google Scholar
• Rothenberger A, Kostanecka T, Kinkelbur J, Cohrs S, Woerner W, Hajak G. Sleep and Tourette syndrome.Adv Neurol 85: 245–259, 2001.
  PubMed CAS Google Scholar
• Kostanecka-Endress T, Banaschewski T, Kinkelbur J, Wullner I, Lichtblau S, Cohrs S et al. Disturbed sleep in children with Tourette syndrome: a polysomnographic study.J Psychosom Res 55: 23–29, 2003.
  Article PubMed Google Scholar
• Peterson, BS, Staib L, Scahill L, Zhang H, Anderson C, Leckman JF et al. Regional brain and ventricular volumes in Tourette syndrome.Arch Gen Psychiatry 58: 427–440, 2001.
  Article PubMed CAS Google Scholar
• Singer HS, Szymanski S, Giuliano J, Yokoi F, Dogan AS, Brasic JR et al. Elevated intrasynaptic dopamine release in Tourette’s syndrome measured by PET.Am J Psychiatry 159: 1329–1336. 2002.
  Article PubMed Google Scholar
• Peterson BS, Thomas P, Kane MJ, Scahill L, Zhang H, Bronen R et al. Basal ganglia volumes in patients with Gilles de la Tourette syndrome.Arch Gen Psychiatry 60: 415–424, 2003.
  Article PubMed Google Scholar
• Kumar R, Lang AE. Tourette syndrome: secondary tic disorders.Neurol Clin 15: 309–331, 1997.
  Article PubMed CAS Google Scholar
• Murphy TK, Sajid M, Soto O, Shapira N, Edge P, Yang M. Detecting pediatric autoimmune neuropsychiatric disorders associated with streptococcus in children with obsessive-compulsive disorder and tics.Biol Psychiatry 55: 61–68, 2004.
  Article PubMed Google Scholar
• Swedo SE. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS).Mol Psychiatry 7: S24-S25, 2002.
  Article PubMed Google Scholar
• Hallett JJ, Kiessling LS. Neuroimmunology of tics and other childhood hyperkinesias.Neurol Clin 15: 333–344, 1997.
  Article PubMed CAS Google Scholar
• Singer HS, Guiliano JD, Hansen BH, Hallett JJ, Laurino JP, Benson M et al. Antiobodies against human putamen in children with Tourette syndrome.Neurology 50: 1618–1624, 1998.
  Article PubMed CAS Google Scholar
• Morshed SA, Parveen S, Leckman JF, Mercadante MT, Bittencourt Kiss MH, Miguel EC et al. Antibodies against neural, nuclear, cytoskeletal, and streptococcal epitopes in children and adults with Tourette’s syndrome, Sydenham’s chorea, and autoimmune disorders.Biol Psychiatry 50: 566–577, 2001.
  Article PubMed CAS Google Scholar
• Loiselle CR, Wendlandt JT, Rohde CA, Singer HS. Antistreptococcal, neuronal, and nuclear antibodies in Tourette syndrome.Pediatr Neurol 28: 119–125, 2003.
  Article PubMed Google Scholar
• Hallett JJ, Harling-Berg CJ, Knopf PM, Stopa EG, Kiessling LS. Anti-striatal antibodies in Tourette syndrome cause neuronal dysfunction.J Neuroimmunol 111: 195–202, 2000.
  Article PubMed CAS Google Scholar
• Taylor JR, Morshed SA, Parveen S, Mercadante MT, Scahill L, Peterson BS et al. An animal model of Tourette’s syndrome.Am J Psychiatry 159: 657–660, 2002.
  Article PubMed Google Scholar
• Church AJ, Dale RC, Lees AJ, Giovannoni G, Robertson MM. Tourette’s syndrome: a cross sectional study to examine the PANDAS hypothesis.J Neurol Neurosurg Psychiatry 74: 602–607. 2003.
  Article PubMed CAS Google Scholar
• Loiselle CR, Lee O, Moran TH, Singer HS. Striatal microinfusion of Tourette syndrome and PANDAS sera: failure to induce behavioral changes.Mov Disord 19: 390–396, 2004.
  Article PubMed Google Scholar
• Garvey MA, Perlmutter SJ, Allen AJ, Hamburger S, Lougee L, Leonard HL et al. A pilot study of penicillin prophylaxis for neuropsychiatrie exacerbations triggered by streptococcal infections.Biol Psychiatry 45: 1564–1571, 1999.
  Article PubMed CAS Google Scholar
• Perlmutter SJ, Leitman SF, Garvey MA, Hamburger S, Feldman E, Leonard HL et al. Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood.Lancet 354: 1153–1158, 1999.
  Article PubMed CAS Google Scholar
• Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL et al. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability.Arch Gen Psychiatry 46: 1006–1011, 1989.
  Article PubMed CAS Google Scholar
• Goodman WK, Rice LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR et al. The Yale-Brown Obsessive Compulsive Scale. II. Validity.Arch Gen Psychiatry 46: 1012–1016, 1989.
  Article PubMed CAS Google Scholar
• Cooper J. The Leyton obsessional inventory.Psychol Med 1: 48–64, 1970.
  Article PubMed CAS Google Scholar
• Berg CJ, Rapoport JL, Flament M. The Leyton obsessional inventory: child version.J Am Acad Child Adolesc Psychiatry 25: 84–91, 1986.
  Article CAS Google Scholar
• Berg CZ, Whitaker A, Davies M, Flament MF, Rapoport JL. The survey form of the Leyton obsessional inventory: child version. Norms from an epidemiological study.J Am Acad Child Adolesc Psychiatry 27: 759–763, 1988.
  Article PubMed CAS Google Scholar
• Leckman JF, Walker DE, Goodman WK, Pauls DL, Cohen DJ. “Just right” perceptions associated with compulsive behavior in Tourette’s syndrome.Am J Psychiatry 151: 675–680, 1994.
  PubMed CAS Google Scholar
• Goyette CH, Conners CK, Ulrich RF. Normative data on revised Conners Parent and Teacher Rating scales.J Abnorm Child Psychol 6: 221–236, 1978.
  Article PubMed CAS Google Scholar
• DuPaul GJ, Power TJ, McGoey KE, Ikeda MJ, Anastopoulos AD. Reliability and validity of parent and teacher ratings of attention-deficit/hyperactivity disorder symptoms.J Psychoeduc Assess 16: 55–68, 1998.
  Article Google Scholar
• Swanson J, Lerner M, March J, Gresham FM. Assessment and intervention for attention-deficit/hyperactivity disorder in the schools: lessons from the MTA study.Pediatr Clin North Am 46: 993–1009, 1999.
  Article PubMed CAS Google Scholar
• MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD: a 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder.Arch Gen Psychiatry 56: 1073, 1999.
  Article Google Scholar
• Schultz RT, Carter AS, Gladstone M, Scahill L, Leckman JF, Peterson BS et al. Visual-motor integration functioning in children with Tourette syndrome.Neuropsychology 12: 134–145, 1998.
  Article PubMed CAS Google Scholar
• Como PG. Neuropsychological function in Tourette syndrome.Adv Neurol 85: 103–111, 2001.
  PubMed CAS Google Scholar
• Jobson KO, Potter WZ. International Psychopharmacology Algorithim Project Report: introduction.Psychopharmacol Bull 31: 457–459, 1995.
  PubMed CAS Google Scholar
• Ross MS, Moldofsky H. A comparison of pimozide and haloperidol in the treatment of Gilles de la Tourette syndrome.Am J Psychiatry 135: 585–587, 1978.
  PubMed CAS Google Scholar
• Shapiro AK, Shapiro E. Controlled study of pimozide vs placebo in Tourette’s syndrome.J Am Acad Child Adolesc Psychiatry 23: 161–173, 1984.
  Article CAS Google Scholar
• Shapiro E, Shapiro AK, Fulop G, Hubbard M, Mandell J, Nordlie J et al. Controlled study of haloperidol, pimozide, and placebo for the treatment of Gilles de la Tourette’s syndrome.Arch Gen Psychiatry 46: 722–730, 1989.
  Article PubMed CAS Google Scholar
• Sallee FR, Nesbitt L, Jackson C, Sine L, Sethuraman G. Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette’s disorder.Am J Psychiatry 154: 1057–1062, 1997.
  PubMed CAS Google Scholar
• Kurlan R. Treatment of tics.Neurol Clin North Am 15: 403–409, 1997.
  CAS Google Scholar
• Riddle MA, Carlson J. Clinical psychopharmacology for Tourette syndrome and associated disorders.Adv Neurol 85: 343–354, 2001.
  PubMed CAS Google Scholar
• Scahill L, Chappell PB, King RA, Leckman JF. Pharmacological treatment of tic disorders.Child Adolesc Psychiatr Clin North Am 9: 99–117, 2000.
  CAS Google Scholar
• Borison RL, Ang L, Chang S, Dysken M, Comaty JE, Davis JM. New pharmacological approaches in the treatment of Tourette syndrome.Adv Neurol 35: 377–382, 1982.
  PubMed CAS Google Scholar
• Goetz CG, Tanner CM, Klawans HL. Fluphenazine and multifocal tic disorders.Arch Neurol 41: 271–272, 1984.
  Article PubMed CAS Google Scholar
• Silay YS, Vuong KD, Jankovic J. The efficacy and safety of fluphenazine in patients with tourette syndrome.Neurology 62: A506, 2004.
  Article Google Scholar
• Caine ED, Polinsky RJ, Kartzinel R, Ebert MH. The trial use of clozapine for abnormal involuntary disorders.Am J Psychiatry 136: 317–320, 1979.
  PubMed CAS Google Scholar
• Dion Y, Annable L, Sandor P, Chouinard G. Risperidone in the treatment of tourette syndrome: a double-blind, placebo-controlled trial.J Clin Psychopharmacol 22: 31–39, 2002.
  Article PubMed CAS Google Scholar
• Scahill L, Leckman JF, Schultz RT, Katsovich L, Peterson BS. A placebo-controlled trial of risperidone in Tourette syndrome.Neurology 60: 1130–1135, 2003.
  Article PubMed CAS Google Scholar
• Bruggeman R, van der Linden C, Buitelaar JK, Gericke GS, Hawkridge SM, Temlett JA. Risperidone versus pimozide in Tourette’s syndrome: a comparative double-blind parallel group study.J Clin Psychiatry 62: 50–56, 2001.
  Article PubMed CAS Google Scholar
• Gilbert DL, Batterson JR, Sethuraman G, Sallee FR. Tic reduction with risperidone versus pimozide in a randomized, double-blind, crossover trial.J Am Acad Child Adolesc Psychiatry 43: 206–214, 2004.
  Article PubMed Google Scholar
• Gaffney GR, Perry PJ, Lund BC, Bever-Stille KA, Arndt S, Kuperman S. Risperidone versus clonidine in the treatment of children and adolescents with Tourette’s syndrome.J Am Acad Child Adolesc Psychiatry 41: 330–336, 2002.
  Article PubMed Google Scholar
• Budman CL, Gayer A, Lesser M, Shi Q, Bruun RD. An open-label study of the treatment efficacy of olanzapine for Tourette’s disorder.J Clin Psychiatry 62: 290–294, 2001.
  Article PubMed CAS Google Scholar
• Stamenkovic M, Schindler SD, Aschauser HN, DeZwaan M, Willinger U, Resinger E et al. Effective open-label treatment of Tourette’s disorder with olanzapine.Int Clin Psychopharmacol 15: 23–28, 2000.
  Article PubMed CAS Google Scholar
• Sallee FR, Kurlan R, Goetz CG, Singer H, Scahill L, Law G et al. Ziprasidone treatment of children and adolescents with Tourette’s syndrome: a pilot study.J Am Acad Child Adolesc Psychiatry 39: 292–299, 2000.
  Article PubMed CAS Google Scholar
• Mukaddes NM, Abali O. Quetiapine treatment of children and adolescents with Tourette’s disorder.J Child Adolesc Psychopharmacol 13: 295–299, 2003.
  Article PubMed Google Scholar
• Kastrup A, Schlotter W, Plewnia C, Bartels M. Treatment of tics in Tourette syndrome with aripiprazole.J Clin Psychopharmacol 25: 94–96, 2005.
  Article PubMed Google Scholar
• Eggers CH, Rothenberger A, Berghaus U. Clinical and neurobiological findings in children suffering from tic disease following treatment with tiapride.Eur Arch Psychiatry Neurol Sci 237: 223–229, 1988.
  Article PubMed CAS Google Scholar
• Robertson MM, Schnieden V, Lees AJ. Management of Gilles de la Tourette syndrome using sulpiride.Clin Neuropharmacol 3: 229–235, 1990.
  Article Google Scholar
• Bruun RD. Subtle and unrecognized side effects of neuroleptic treatment in children with Tourette’s disorder.Am J Psychiatry 145: 621–624, 1988.
  PubMed CAS Google Scholar
• Allison DB, Casey DE. Antipsychotic-induced weight gain: a review of the literature.J Clin Psychiatry 62: 22–31, 2001.
  PubMed CAS Google Scholar
• Martin A, Scahill L, Anderson GM, Aman M, Arnold LE, Mc-Cracken J et al. Weight and leptin changes among risperidone-treated youths with autism: 6-month prospective data.Am J Psychiatry 161: 1125–1127, 2004.
  Article PubMed Google Scholar
• Meyer JM, Koro CE. The effects of antipsychotic therapy on serum lipids: a comprehensive review.Schizophr Res 70: 1–17, 2004.
  Article PubMed Google Scholar
• Singer HS. The treatment of tics.Cur Neurol Neurosci Rep 1: 195–202, 2001.
  Article CAS Google Scholar
• Desta Z, Kerbusch T, Flockhart DA. Effect of clarithromycin on the pharmacokinetics and pharmacodynamics of pimozide in healthy poor and extensive metabolizers of cytochrome P450 2D6 (CYP2D6).Clin Pharmacol Ther 65: 10–20, 1999.
  Article PubMed CAS Google Scholar
• Zareba W, Lin DA. Antipsychotic drugs and QT interval prolongation.Psychiatr Q 74: 291–306, 2003.
  Article PubMed Google Scholar
• U.S. Food and Drug Administration. NDA 20-825 approval letter and labeling for ziprasione. Available at: http://www.fda.gov/ cder/foi/label, 2001. Accessed March 2004.
• Blair J, Scahill L, State M, Martin A. Electrocardiographic changes in children and adolescents treated with ziprasidone: a prospective study.J Am Acad Child Adolesc Psychiatry 44: 73–79, 2005.
  Article PubMed Google Scholar
• Cohen DJ, Young JG, Nathanson JA, Shaywitz BA. Clonidine in Tourette’s syndrome.Lancet 2: 551–553, 1979.
  Article PubMed CAS Google Scholar
• American Academy of Child and Adolescent Psychiatry. Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit hyperactivity disorder.J Am Acad Child Adolesc Psychiatry 36: 85S-121S, 1997.
  Article Google Scholar
• Gutgesell H, Atkins D, Barst R, Buck M, Franklin W, Humes R et al. Cardiovascular monitoring of children and adolescents receiving psychotropic drugs: a statement for healthcare professionals from the Committee on Congenital Cardiac Defects, Council on Cardiovascular Disease in the Young, American Heart Association.Circulation 99: 979–982, 1999.
  Article PubMed CAS Google Scholar
• Leckman JF, Ort S, Caruso KA, Anderson GM, Riddle MA, Cohen DJ. Rebound phenomena in Tourette’s syndrome after abrupt withdrawal of clonidine.Arch Gen Psychiatry 43: 1168–1176, 1986.
  Article PubMed CAS Google Scholar
• Scahill L, Chappell PB, Kim YS, Schultz RT, Katsovich L, Shepherd E et al. Guanfacine in the treatment of children with tic disorders and ADHD: a placebo-controlled study.Am J Psychiatry 158: 1067–1074, 2001.
  Article PubMed CAS Google Scholar
• Cummings DD, Singer HS, Krieger M, Miller TL, Mahone EM. Neuropsychiatric effects of guanfacine in children with mild Tourette syndrome: a pilot study.Clin Neuropharmacol 25: 325–332, 2002.
  Article PubMed CAS Google Scholar
• Kurlan R, Como PG, Deeley C, McDermott M, McDermott MP. A pilot controlled study of fluoxetine for obsessive-compulsive symptoms in children with Tourette’s syndrome.Clin Neuropharmacol 16: 167–172, 1993.
  Article PubMed CAS Google Scholar
• Scahill L, Riddle MA, King RA, Hardin MT, Rasmusson A, Makuch RW et al. Fluoxetine has no marked effect on tic symptoms in patients with Tourette’s syndrome: a double-blind placebo-controlled study.J Child Adolesc Psychopharmacol 7: 75, 1997.
  Article PubMed CAS Google Scholar
• Jankovic J, Orman J. Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias.Neurology 38: 391–394, 1988.
  Article PubMed CAS Google Scholar
• Jankovic J, Beach J. Long-term effects of tetrabenazine in hyperkinetic movement disorders.Neurology 48: 358–362, 1997.
  Article PubMed CAS Google Scholar
• Lipinski JF, Sallee FR, Jackson C, Sethuraman G. Dopamine agonist treatment of Tourette disorder in children: results of an open-label trial of pergolide.Mov Disord 12: 402–407, 1997.
  Article PubMed CAS Google Scholar
• Gilbert DL, Sethuraman G, Sine L, Peters S, Sallee FR. Tourette’s syndrome improvement with pergolide in a randomized, double-blind, crossover trial.Neurology 54: 1310–1315. 2000.
  Article PubMed CAS Google Scholar
• Gilbert DL, Dure L, Sethuraman G, Raab D, Lane J, Sallee FR. Tic reduction with pergolide in a randomized controlled trial in children.Neurology 60: 606–611, 2003.
  Article PubMed CAS Google Scholar
• Goetz CG, Stebbins GT, Thelen JA. Talipexole and adult Gilles de la Tourette’s syndrome: double-blind, placebo-controlled clinical trial.Mov Disord 9: 315–317, 1994.
  Article PubMed CAS Google Scholar
• Awaad Y. Tics in Tourette syndrome: new treatment options.J Child Neurol 14: 316–319, 1999.
  Article PubMed CAS Google Scholar
• Jankovic J. Botulinum toxin in the treatment of dystonic tics.Mov Disord 9: 347–349, 1994.
  Article PubMed CAS Google Scholar
• Kwak CH, Hanna PA, Jankovic J. Botulinum toxin in the treatment of tics.Arch Neurol 57: 1190–1193, 2000.
  Article PubMed CAS Google Scholar
• Manas C, Andrews D, Sime E, Lang AE. Botulinum toxin for simple motor tics: a randomized, double-blind, controlled clinical trial.Neurology 56: 605–610, 2001.
  Article Google Scholar
• Porta M, Maggioni G, Ottaviani F, Schindler A. Treatment of phonic tics in patients with Tourette’s syndrome using botulinum toxin type A.Neurol Sci 24: 420–423, 2004.
  Article PubMed CAS Google Scholar
• Gonce M, Barbeau A. Seven cases of Gilles de la Tourette’s syndrome: partial relief with clonazepam. A pilot study.Can J Neurol Sci 3: 279–283, 1977.
  Google Scholar
• Steingard RJ, Goldberg M, Lee D, DeMaso DR. Adjunctive clonazepam treatment of tic symptoms in children with comorbid tic disorders and ADHD.J Am Acad Child Adolesc Psychiatry 33: 394–399, 1994.
  Article PubMed CAS Google Scholar
• Graae F, Milner J, Rizzotto L, Klein RG. Clonazepam in childhood anxiety disorders.J Am Acad Child Adolesc Psychiatry 33: 372–376, 1994.
  Article PubMed CAS Google Scholar
• Singer HS, Wendlandt J, Krieger M, Giuliano J. Baclofen treatment in Tourette syndrome: a double-blind, placebo-controlled, crossover trial.Neurology 56: 599–604, 2001.
  Article PubMed CAS Google Scholar
• Abuzzahab FS, Brown VL. Control of Tourette’s syndrome with topiramate.Am J Psychiatry 158: 968, 2001.
  PubMed CAS Google Scholar
• Awaad Y, Michon AM, Minarik S. Use of levetiracetam to treat tics in children and adolescents with Tourette syndrome.Mov Disord 20: 714–718, 2005.
  Article PubMed Google Scholar
• Fraunfelder FW, Fraunfelder FT. Adverse ocular drug reactions recently identified by the National Registry of Drug-Induced Ocular Side Effects.Ophthalmology 111: 1275–1279, 2004.
  Article PubMed CAS Google Scholar
• Sanberg PR, McConville BJ, Fogelson HM, Manderscheid PZ, Parker KW, Blythe MM et al. Nicotine potentiates the effects of haloperidol in animals and in patients with Tourette syndrome.Biomed Pharmacother 43: 19, 1989.
  Article PubMed CAS Google Scholar
• McConville BJ, Sanberg PR, Fogelson MH, King J, Cirino P, Parker KW et al. The effects of nicotine plus haloperidol compared to nicotine only and placebo nicotine only in reducing tic severity and frequency in Tourette’s disorder.Biol Psychiatry 15: 832–840, 1992.
  Article Google Scholar
• Silver AA, Shytle RD, Philipp MK, Wilkinson BJ, McConville B, Sanberg PR. Transdermal nicotine and haloperidol in Tourette’s disorder: a double-blind placebo-controlled study.J Clin Psychiatry 62: 707–714, 2001.
  Article PubMed CAS Google Scholar
• Shytle RD, Silver AA, Sheehan KH, Sheehan DV, Sanberg PR. Neuronal nicotinic receptor inhibition for treating mood disorders: preliminary controlled evidence with mecamylamine.Depress Anxiety 16: 89–92, 2002.
  Article PubMed Google Scholar
• Silver AA, Shytle RD, Sheehan KH, Sheehan DV, Ramos A, Sanberg PR. Multicenter, double-blind, placebo-controlled study of mecamylamine monotherapy for Tourette’s disorder.J Am Acad Child Adolesc Psychiatry 40: 1103–1110, 2001.
  Article PubMed CAS Google Scholar
• Peterson BS, Zhang H, Bondi C, Naftolin F, Leckman JF. A double-blind, placebo-controlled, crossover trial of an antiandrogen in the treatment of Tourette’s syndrome.J Clin Psychopharmacol 18: 324–331, 1998.
  Article PubMed CAS Google Scholar
• Leonard HL, Swedo SE, Rapoport JL, Koby EV, Lenane MC, Cheslow DL et al. Treatment of obsessive compulsive disorder with clomipramine and desipramine in children and adolescents.Arch Gen Psychiatry 46: 1088–1092, 1989.
  Article PubMed CAS Google Scholar
• DeVeaugh-Geiss J, Katz R, Landau P, Goodman W, Rasmussen S. Clinical predictors of treatment response in obsessive compulsive disorder: exploratory analyses from multicenter trials of clomipramine.Psychopharmacol Bull 26: 54–59, 1990.
  PubMed CAS Google Scholar
• DeVeaugh-Geiss J, Moroz G, Biederman J, Cantwell D, Fontaine R, Greist JH et al. Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder: a multicenter trial.J Am Acad Child Adolesc Psychiatry 31: 45–49, 1992.
  Article PubMed CAS Google Scholar
• Kaplan A, Hollander E. A review of pharmacologic treatments for obsessive-compulsive disorder.Psychiatr Serv 54: 1111–1118. 2003.
  Article PubMed Google Scholar
• Jenike MA. Clinical practice. Obsessive-compulsive disorder.N Engl J Med 350: 259–265, 2004.
  Article PubMed CAS Google Scholar
• Montgomery SA, Kasper S, Stein DJ, Bang Hedegaard K, Lemming OM. Citalopram 20 mg, 40 mg and 60 mg are all effective and well tolerated compared with placebo in obsessive-compulsive disorder.Int Clin Psychopharmacol 16: 75–86, 2001.
  Article PubMed CAS Google Scholar
• March JS, Biederman J, Wolkow R, Safferman A, Mardekian J, Cook EH et al. Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial.JAMA 280: 1752–1156, 1998.
  Article PubMed CAS Google Scholar
• Geller DA, Hoog SL, Heiligenstein JH, Ricardi RK, Tamura R, Kluszynski S et al. Fluoxetine Pediatric OCD Study Team. Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: a placebo-controlled clinical trial.J Am Acad Child Adolesc Psychiatry 40: 773–779, 2001.
  Article PubMed CAS Google Scholar
• Riddle MA, Reeve EA, Yaryura-Tobias JA, Yang HM, Claghom JL, Gaffney G et al. Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled, multicenter trial.J Am Acad Child Adolesc Psychiatry 40: 222–229, 2001.
  Article PubMed CAS Google Scholar
• Liebowitz MR, Turner SM, Piacentini J, Beidel DC, Clarvit SR, Davies SO et al. Fluoxetine in children and adolescents with OCD: a placebo-controlled trial.J Am Acad Child Adolesc Psychiatry 41: 1431–1438, 2002.
  Article PubMed Google Scholar
• Geller DA, Wagner KD, Emslie G, Murphy T, Carpenter DJ, Wetherhold E et al. Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: a randomized, multi-center, double-blind, placebo-controlled trial.J Am Acad Child Adolesc Psychiatry 43: 1387–1396, 2004.
  Article PubMed Google Scholar
• Pediatric OCD Treatment Study (POTS) Team. Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: The Pediatric OCD Treatment Study (POTS) randomized controlled trial.JAMA 292: 1969–1976, 2004.
  Article Google Scholar
• Riddle MA, King RA, Hardin MT, Scahill L, Ort SI, Leckman JF. Behavioral side effects of fluoxetine.J Child Adolesc Psychopharmacol 3: 193–198, 1991.
  Google Scholar
• U.S. Food and Drug Administration. Labeling Change Request Letter for Antidepressant Medications. Available at: http://www. fda.gov/cder/drug/antidpressants/SSRI labeling, Accessed October 15, 2004.
• King RA, Riddle MA, Chappell PB, Hardin MT, Anderson GM, Lombroso P et al. Emergence of self-destructive phenomena in children and adolescents during fluoxetine treatment.J Am Acad Child Adolesc Psychiatry 30: 179–186, 1991.
  Article PubMed CAS Google Scholar
• Oesterheld JR. Erythromycin and clomipramine: noncompetitive inhibition of demethylation.J Child Adolesc Psychopharmacol 6: 211–213, 1996.
  Article PubMed CAS Google Scholar
• Rosenbaum JF, Fava M, Pava JA, McCarthy MK, Steingard RJ, Bouffides E. Anger attacks in unipolar depression. Part 2: Neuroendocrine correlates and changes following fluoxetine treatment.Am J Psychiatry 150: 1164–1168, 1993.
  PubMed CAS Google Scholar
• Hollander E, Bienstock CA, Koran LM, Pallanti S, Marazziti D, Rasmussen SA, et al. Refractory obsessive-compulsive disorder: state-of-the-art treatment.J Clin Psychiatry 63: 20–29, 2002.
  PubMed Google Scholar
• Varley CK. Sudden death related to selected tricyclic antidepressants in children: epidemiology, mechanisms and clinical implications.Paediatr Drugs 3: 613–627, 2001.
  Article PubMed CAS Google Scholar
• Expert Consensus Panel for Obsessive-Compulsive Disorder. Treatment of obsessive-compulsive disorder.J Clin Psychiatry 58: 2–72, 1997.
  Google Scholar
• Wameke LB. The use of intravenous chlorimipramine in the treatment of obsessive compulsive disorder.Can J Psychiatry 29: 135–141, 1984.
  Google Scholar
• Koran LM, Pallanti S, Paiva RS, Quercioli L. Pulse loading versus gradual dosing of intravenous clomipramine in obsessive-compulsive disorder.Eur Neuropsychopharmacol 8: 121–126, 1998.
  Article PubMed CAS Google Scholar
• Sallee FR, Koran LM, Pallanti S, Carson SW, Sethuraman G. Intravenous clomipramine challenge in obsessive-compulsive disorder: predicting response to oral therapy at eight weeks.Biol Psychiatry 44: 220–227, 1998.
  Article PubMed CAS Google Scholar
• Greenhill LL, Abikoff HB, Arnold LE, Cantwell DP, Conners CK, Elliott G et al. Medication treatment strategies in the MTA study: relevance to clinicians and researchers.J Am Acad Child Adolesc Psychiatry 35: 1304–1313, 1996.
  Article PubMed CAS Google Scholar
• Elia J, Borcherding BG, Rapoport JL, Keysor CS. Methylphenidate and dextroamphetamine treatments of hyperactivity: are there true non-responders?Psychiatr Res 36: 141–155, 1991.
  Article CAS Google Scholar
• Erenberg G, Cruse RP, Rothner AD. Gilles de la Tourette’s syndrome: effects of stimulant drugs.Neurology 35: 1346–1348. 1985.
  Article PubMed CAS Google Scholar
• Golden GS. Gilles de la Tourette’s syndrome following methyl-phenidate administration.Dev Med Child Neurol 16: 76–78, 1974.
  Article PubMed CAS Google Scholar
• Lowe TL, Cohen DJ, Detlor J, Kremenitzer MW, Shaywitz BA. Stimulant medications precipitate Tourette’s syndrome.JAMA 26: 1729–1731, 1992.
  Google Scholar
• Lipkin PH, Goldstein IJ, Adesman AR. Tics and dyskinesias associated with stimulant treatment in attention-deficit hyperactivity disorder.Arch Pediatr Adolesc Med 148: 859–861, 1994.
  Article PubMed CAS Google Scholar
• Riddle MA, Lynch KA, Scahill L. Methylphenidate discontinuation during long-term treatment of children with Tourette’s disorder and attention deficit hyperactivity disorder: a pilot study.J Child Adolesc Psychopharmacol 5: 205–214, 1995.
  Article Google Scholar
• Varley CK, Vincent J, Varley P, Calderon R. Emergence of tics in children with attention deficit hyperactivity disorder treated with stimulant medications.Comp Psychiatry 42: 228–233, 2001.
  Article CAS Google Scholar
• Barkley RA, McMurray MB, Edelbrock CS, Robbins K. Side effects of methylphenidate in children with attention deficit hyperactivity disorder: a systemic, placebo-controlled evaluation.Pediatrics 86: 184–192, 1992.
  Google Scholar
• Borcherding BG, Keysor CS, Rapoport JL, Elia J, Amass J. Motor/vocal tics and compulsive behaviors on stimulant drugs: is there a common vulnerability?Psychiatry Res 33: 83–94, 1990.
  Article PubMed CAS Google Scholar
• Castellanos FX, Geidd JN, Elia J. Controlled stimulant treatment of ADHD and comorbid Tourette’s syndrome: effects of stimulant and dose.J Am Acad Child Adolesc Psychiatry 36: 589–596, 1997.
  Article PubMed CAS Google Scholar
• Gadow KD, Sverd J, Sprafkin J, Nolan EE, Ezor SN. Efficacy of methylphenidate for attention-deficit hyperactivity disorder in children with tic disorder.Arch Gen Psychiatry 52: 444–455. 1995.
  Article PubMed CAS Google Scholar
• Tourette Syndrome Study Group. Treatment of ADHD in children with tics: a randomized controlled trial.Neurology 58: 527–536, 2002.
  Article Google Scholar
• Gadow KD, Sverd J, Sprafkin J, Nolan EE, Grossman S. Long-term methylphenidate therapy in children with comorbid attention-deficit hyperactivity dsorder and chronic multiple tic disorder.Arch Gen Psychiatry 56: 330–336, 1999.
  Article PubMed CAS Google Scholar
• Law SF, Schachar RJ. Do typical clinical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder?J Am Acad Child Adolesc Psychiatry 38: 944–951. 1999.
  Article PubMed CAS Google Scholar
• Biederman J, Baldessarini RJ, Wright V, Knee D, Harmatz JS. A double-blind placebo controlled study of desipramine in the treatment of ADD. I. Efficacy.J Am Acad Child Adolesc Psychiatry 28: 777–784, 1989.
  Article PubMed CAS Google Scholar
• Singer H, Brown J, Quaskey S, Rosenberg LA, Mellits ED, Denckla MB. The treatment of attention-deficit hyperactivity disorder in Tourette’s syndrome: a double-blind placebo-controlled study with clonidine and desipramine.Pediatrics 95: 74–81, 1995.
  PubMed CAS Google Scholar
• Spencer T, Biederman J, Coffey B, Geller D, Crawford M, Bearman SK et al. A double-blind comparison of desipramine and placebo in children and adolescents with chronic tic disorder and comorbid attention-deficit/hyperactivity disorder.Arch Gen Psychiatry 59: 649–656, 2002.
  Article PubMed CAS Google Scholar
• Riddle MA, Geller B, Ryan N. Another sudden death in a child treated with desipramine.J Am Acad Child Adolesc Psychiatry 32: 792–797, 1993.
  Article PubMed CAS Google Scholar
• Barrickman L, Perry P, Allen A, Kuperman S, Arndt S, Herrmann K, et al. Buproprion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder.J Am Acad Child Adolesc Psychiatry 34: 649–657, 1995.
  Article PubMed CAS Google Scholar
• Casat CD, Pleasants DZ, Van Wyck Fleet J. A double-blind trial of bupropion in children with attention deficit disorder.Psychopharmacol Bull 23: 120–122, 1987.
  PubMed CAS Google Scholar
• Casat CD, Pleasants DZ, Schroeder DH, Parler DW. Bupropion in children with attention deficit disorder.Psychopharmacol Bull 25: 198–201, 1989.
  PubMed CAS Google Scholar
• Conners CK, Casat CD, Gualtieri CT, Weller E, Reader M, Reiss A et al. Bupropion hydrochloride in attention deficit disorder with hyperactivity.J Am Acad Child Adolesc Psychiatry 34: 1314–1321, 1996.
  Article Google Scholar
• Spencer T, Biederman J, Steingard R, Wilens T. Bupropion exacerbates tics in children with attention-deficit hyperactivity disorder and Tourette’s syndrome.J Am Acad Child Adolesc Psychiatry 32: 211–214, 1993.
  Article PubMed CAS Google Scholar
• Belson MG, Kelley TR. Bupropion exposures: clinical manifestations and medical outcome.J Emerg Med 23: 223–230, 2002.
  Article PubMed Google Scholar
• Buitelaar JK, van der Gaag RJ, Swaab-Bameveld H, Kuiper M. Pindolol and methylphenidate in children with attention-deficit hyperactivity disorder: clinical efficacy and side-effects.J Child Psychol Psychiatry 37: 587–595, 1996.
  Article PubMed CAS Google Scholar
• Feigin A, Kurlan R, McDermott MP, Beach J, Dimitsapulos T, Brower CA et al. A controlled trial of deprenyl in children with Tourette’s syndrome and attention deficit hyperactivity disorder.Neurology 46: 965–968, 1996.
  Article PubMed CAS Google Scholar
• Hunt RD, Minderaa RB, Cohen DJ. Clonidine benefits children with attention deficit disorder and hyperactivity: report of a double-blind placebo-crossover therapeutic trial.J Am Acad Child Adolesc Psychiatry 24: 617–629, 1985.
  Article CAS Google Scholar
• Connor DF, Barkery RA, Davis HT. A pilot study of methylphenidate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder.Clin Pediatr 39: 15–25, 2000.
  Article CAS Google Scholar
• Rapport MD, Denney C, DuPaul GJ, Gardener M. Attention deficit disorder and methylphenidate: normalization rates, clinical effectiveness, and response prediction in 76 children.J Am Acad Child Adolesc Psychiatry 33: 882–893, 1994.
  Article PubMed CAS Google Scholar
• Hunt RD, Amsten AFT, Asbell MD. An open trial of guanfacine in phe nidatef or attention deficit hyperactivity disorder.J Am Acad Child Adolesc Psychiatry 34: 50–54, 1995.
  Article PubMed CAS Google Scholar
• Horrigan JP, Bamhill LJ. Guanfacine for treatment of attention-deficit hyperactivity disorder in boys.J Child Adolesc Psychopharmacol 5: 215–223, 1995.
  Article Google Scholar
• Chappell PB, Riddle MA, Scahill L, Lynch KA, Schultz R, Amsten A et al. Guanfacine treatment of comorbid attention-deficit hyperactivity disorder in Tourette’s syndrome: preliminary clinical experience.J Am Acad Child Adolesc Psychiatry 34: 1140–1146, 1995.
  Article PubMed CAS Google Scholar
• Solanto MV, Amsten AFT, Catellanos FX. Stimulant drugs and ADHD: basic and clinical neuroscience. New York: Oxford, 2001.
  Google Scholar
• Sukhodolsky D, Scahill L, Zhang H, Peterson BS, King RA, Lombroso PJ et al. Disruptive behavior in children with Tourette’ s syndrome: association of ADHD comorbidity, tic severity, and functional impairment.J Am Acad Child Adolesc Psychiatry 42: 98–105, 2003.
  Article PubMed Google Scholar
• Michelson D, Faries D, Wemicke J, Kelsey D, Kendrick K, Sallee FR et al. Atomoxetine ADHD Study Group. Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study.Pediatrics 108: E83, 2001.
  Article PubMed CAS Google Scholar
• Michelson D, Allen AJ, Busner J, Casat C, Dunn D, Kratochvil C et al. Once daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study.Am J Psychiatry 159: 1896, 2002.
  Article PubMed Google Scholar
• Berthier ML, Kulisevsky J, Campos VM. Bipolar disorder in adult patients with Tourette’s syndrome: a clinical study.Biol Psychiatry 43: 364–370, 1998.
  Article PubMed CAS Google Scholar
• Comings BG, Comings DE. A controlled study of Tourette syndrome. V. Depression and mania.Am J Hum Genet 41: 804–821, 1987.
  PubMed CAS Google Scholar
• Comings DE, Comings BG. A controlled study of Tourette syndrome. III. Phobias and panic attacks.Am J Hum Genet 41: 761–781, 1987.
  PubMed CAS Google Scholar
• Comings DE, Comings BG. A controlled family history study of Tourette’s syndrome. III. Affective and other disorders.J Clin Psychiatry 51: 288–291, 1990.
  PubMed CAS Google Scholar
• Coffey BJ, Biederman J, Smoller JW, Geller DA, Sarin P, Schwartz S et al. Anxiety disorders and tic severity in juveniles with Tourette’s disorder.J Am Acad Child Adolesc Psychiatry 39: 562–568, 2000.
  Article PubMed CAS Google Scholar
• Coffey BJ, Park KS. Behavioral and emotional aspects of Tourette syndrome.Neurol Clin 15: 277–289, 1997.
  Article PubMed CAS Google Scholar
• Kerbeshian J, Burd L, Klug MG. Comorbid Tourette’s disorder and bipolar disorder: an etiologic perspective.Am J Psychiatry 152: 1646–1651, 1995.
  PubMed CAS Google Scholar
• Comings DE. Role of genetic factors in depression based on studies of Tourette syndrome and ADHD probands and their relatives.Am J Med Genet 60: 111–121, 1995.
  Article PubMed CAS Google Scholar
• Palumbo D, Maughan A, Kurlan R. Hypothesis: III. Tourette syndrome is only one of several causes of a developmental basal ganglia syndrome.Arch Neurol 54: 475–483, 1997.
  Article PubMed CAS Google Scholar
• King RA, Scahill L. Emotional and behavioral difficulties associated with Tourette syndrome.Adv Neurol 85: 79–88, 2001.
  PubMed CAS Google Scholar
• Fava M, Rush AJ, Trivedi MH, Nierenberg AA, Thase ME, Sackeim HA et al. Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study.Psychiatr Clin North Am 26: 457–494, 2003.
  Article PubMed Google Scholar
• Emslie GJ, Mayes TL. Mood disorders in children and adolescents: psychopharmacological treatment.Biol Psychiatry 49: 1082–1090, 2001.
  Article PubMed CAS Google Scholar
• Sachs GS. Decision tree for the treatment of bipolar disorder.J Clin Psychiatry 64: 35–40, 2003.
  Article PubMed CAS Google Scholar
• Expert Consensus Guideline Series. Treatment of bipolar disorder.J Clin Psychiatry 57: 3–88, 1996.
  Google Scholar
• Gorman JM. Treating generalized anxiety disorder.J Clin Psychiatry 64: 24–29, 2003.
  PubMed Google Scholar
• Budman CL, Bruun RD, Park KS, Lesser M, Olson M. Explosive outbursts in children with Tourette’s disorder.J Am Acad Child Adoles Psychiatry 39: 1270–1276, 2000.
  Article CAS Google Scholar
• Freeman RD, Fast DK, Burd L, Kerbeshian J, Robertson MM, Sandor P. An international perspective on Tourette syndrome: selected findings from 3,500 individuals in 22 countries.Dev Med Child Neurol 42: 436–447, 2000.
  Article PubMed CAS Google Scholar
• Bruun RD, Budman CL. Paroxetine treatment of episodic rages associated with Tourette’s disorder.J Clin Psychiatry 59: 581–584, 1998.
  Article PubMed CAS Google Scholar
• Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. Risperidone in children with autism for serious behavioral problems.N Engl J Med 347: 314–321, 2002.
  Article Google Scholar
• Aman MG, De Smedt G, Derivan A, Lyons B, Findling RL. Risperidone Disruptive Behavior Study Group. Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence.Am J Psychiatry 159: 1337–1346, 2002.
  Article PubMed Google Scholar
• Donovan SJ, Stewart JW, Nunes EV, Quitkin FM, Parides M, Daniel W et al. Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design.Am J Psychiatry 157: 818–820, 2000.
  Article PubMed CAS Google Scholar
• Lombroso PJ, Scahill L, King RA, Lynch KA, Chappell PB, Peterson BS et al. Risperidone treatment of children and adolescents with chronic tic disorders: a preliminary report.J Am Acad Child Adolesc Psychiatry 34: 1147–1152, 1995.
  Article PubMed CAS Google Scholar
• McDougle CJ, Goodman WK, Leckman JF, Lee NC, Heninger GR, Price LH. Haloperidol addition in fluvoxamine-refractory obsessive compulsive disorder: a double-blind, placebo-controlled study in patients with and without tics.Arch Gen Psychiatry 51: 302–308, 1994.
  Article PubMed CAS Google Scholar
• McDougle CJ, Epperson CN, Pelton GH, Wasylink S, Price LH. A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder.Arch Gen Psychiatry 57: 794–801, 2000.
  Article PubMed CAS Google Scholar
• Figueroa Y, Rosenberg DR, Birmaher B, Keshavan MS. Combination treatment with clomipramine and selective serotonin reuptake inhibitors for obsessive-compulsive disorder in children and adolescents.J Child Adolesc Psychopharmacol 8: 61–67, 1998.
  Article PubMed CAS Google Scholar